Quarterly report pursuant to Section 13 or 15(d)

Equity Transactions (Details)

v3.10.0.1
Equity Transactions (Details)
9 Months Ended
Sep. 30, 2018
$ / shares
shares
Number of Options  
Balance at December 31, 2017 | shares 0
Shares acquired in reverse acquisition | shares 1,996
Shares granted during the period | shares 0
Shares exercised during the period | shares (52)
Shares forfeited during the period | shares (26)
Shares expired during the period | shares (15)
Shares outstanding at September 30, 2018 | shares 1,903
Shares exercisable at September 30, 2018 | shares 1,428
Weighted Average Exercise Price  
Balance at December 31, 2017 | $ / shares $ 0.00
Shares acquired in reverse acquisition | $ / shares 3.48
Shares granted during the period | $ / shares 0.00
Shares exercised during the period | $ / shares 2.67
Shares forfeited during the period | $ / shares 2.15
Shares expired during the period | $ / shares 4.28
Shares outstanding at September 30, 2018 | $ / shares 3.50
Shares exercisable at September 30, 2018 | $ / shares $ 3.99
Weighted Average Remaining Contract Term  
Outstanding at September 30, 2018 7 years 6 months 29 days
Exercisable at September 30, 2018 7 years 5 months 8 days